Coffee & Compatibility

HLA Director and Transfusion Medicine Specialist, Dr. Ryan Pena, joins Coffee & Compatibility to discuss how HLA laboratories can support transfusion medicine specialists. From HLA typing to anti-HLA antibody analysis in this niche service, Dr. Pena breaks it all down.

Dr. Gerald Morris, the current Chair of the OPTN Histocompatibility Committee, joins Coffee & Compatibility to discuss upcoming changes in HLA testing and nomenclature, and their potential impacts on organ allocation in the United States.

Dr. Medhat Askar joins the podcast to discuss the utility and validation of donor-derived cell-free DNA (dd-cfDNA) testing for solid-organ recipients. Dr. Askar also discusses the regulatory status of dd-cfDNA in the United States.

Dr. Christina Jorge shares what has made Portugal’s organ allocation system one of the best in the world, as well as the challenges it faces and the innovations it has planned.

Organ allocation expert Larry Suplee joins Coffee & Compatibility to discuss the strengths of the U.S. organ allocation system and explore future improvements.

Trailblazer Donna Phelan shares her journey in HLA including moments of special connection with ASHI’s mission, groundbreaking advances in technology, and paving the way for technologist leadership in ASHI!

Kicking off a celebration of ASHI’s 50th anniversary, the podcast welcomes Dr. Carolyn Hurley for a conversation about the history and future of ASHI.

Coffee & Compatibility jumps into 2024 with Dr. Robert Liwski, who will give best practices advice on ruling spurious reactivity out of your antibody detection assays. This is your opportunity to up your antibody data accuracy game in 2024!

Patrick Wells-O’Brien joins the podcast to discuss a new law in Michigan designed to grow the organ donor registry and how you can initiate similar legislation in your state.